Richard Weisler
Psychiatry · Raleigh, NCNPI 1356522809
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $72,676 of the $107,859 with a category attached, or 67.4%. 14 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 40.0% of the total. Reporting peaked in 2019 at $43,343 and has fallen 99.6% since, to $181 in 2024. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $602.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$43K
- Ironshore Pharmaceuticals Inc.$23K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$13K
- Otsuka America Pharmaceutical, Inc.$10K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- Johnson & Johnson$5K
- plus $5K from 8 others
Across 157 payments — averaging $13,801 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1.4M
- AbbVie$416K
- Janssen Research & Development, LLC$234K
- Supernus Pharmaceuticals, Inc.$92K
What the payments were for
- Consulting fees$22,96521%
- Speaking & faculty fees$72,67667%
- Travel & lodging$5,3715%
- Food & beverage$6,8416%
- Education$30%
- Gifts$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 38 | $43,186 |
| Ironshore Pharmaceuticals Inc. | 44 | $23,362 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 19 | $13,375 |
| Otsuka America Pharmaceutical, Inc. | 7 | $10,096 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $7,567 |
| Johnson & Johnson | 14 | $5,488 |
| Validus Pharmaceuticals LLC | 6 | $1,585 |
| AbbVie(2 entities) | 12 | $920 |
| Neos Therapeutics, LP | 2 | $671 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $631 |
| Neurocrine Biosciences, Inc. | 11 | $457 |
| Alkermes, Inc. | 2 | $212 |
| Teva Pharmaceuticals USA, Inc. | 2 | $196 |
| Sunovion Pharmaceuticals Inc. | 1 | $113 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$39,120
- Jornay PM 20mg capsules (Bottle of 100)$22,789
- VYVANSE$7,335
- REXULTI$6,615
- SPRAVATO$5,089
- Equetro$1,500
- Adzenys XR-ODT$671
- Cotempla XR-ODT$671
- VRAYLAR$669
- ARISTADA$460
- CAPLYTA$324
- INGREZZA$137
- AUSTEDO$125
- ARISTADA INITIO$115
- INVEGA TRINZA$111
- INVEGA SUSTENNA$111
How this compares
$107,859 in reported general payments places this provider in the 95th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Raleigh
- Robert MilletRaleigh$476K
- Ashwin PatkarRaleigh$103K
- Mona GuptaRaleigh$88K
- Kellie TolinRaleigh$31K
- Celso LobaoRaleigh$28K
- Elizabeth CoxRaleigh$24K
- Myleme HarrisonRaleigh$13K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.